BioElectronics Corp. Appoints Charles Gregoire de Rothschild to Post of Special Adviser to Board

FREDERICK, MD -- (MARKET WIRE) -- 05/26/09 -- BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the appointment of international financier Charles Gregoire de Rothschild to the role of Special Adviser to the Company's board of directors. Mr. de Rothschild will support BioElectronics' continuing global expansion efforts by leveraging his extensive domestic and international financial expertise. "I am a strong believer in BioElectronics Corporation's drug-free pain relieving and healing products and see strong revenue and profit growth over the coming years," commented Mr. de Rothschild. "I look forward to helping the Company obtain the capital to allow movement of these exciting products into the mainstream of medical technologies and in assisting in the expansion of worldwide marketing and distribution." "We are excited to be working with Mr. de Rothschild toward the goals of expanding our capital base and acquiring additional international distribution partnerships. We believe his proven track record as a highly successful financier for growth companies, in addition to his strong international contacts, will allow BioElectronics to move a step closer to our goal of worldwide distribution for our advanced solutions for pain management and healing." Mr. de Rothschild, Chairman of GDR Privee, an international investment boutique, has an extensive international banking background and has served in many advisory roles. About BioElectronics Corporation BioElectronics Corporation is the maker of ActiPatch(R) Therapy, RecoveryRx(TM) Devices, HealFast(TM) Therapy ( and the Allay(TM) family of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see For media enquiries, please contact: Joe Noel BioElectronics Corp. (925) 922-2560 This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.